WO2006107134A1 - Method for preparing valienamine - Google Patents

Method for preparing valienamine Download PDF

Info

Publication number
WO2006107134A1
WO2006107134A1 PCT/KR2005/004093 KR2005004093W WO2006107134A1 WO 2006107134 A1 WO2006107134 A1 WO 2006107134A1 KR 2005004093 W KR2005004093 W KR 2005004093W WO 2006107134 A1 WO2006107134 A1 WO 2006107134A1
Authority
WO
WIPO (PCT)
Prior art keywords
valienamine
acarbose
base
hydroxide
amberlite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2005/004093
Other languages
French (fr)
Inventor
Il Suk Byun
Joo Sung Kim
Sung Hye Shin
Wan Joo Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemtech Research Inc
Original Assignee
Chemtech Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020050036755A external-priority patent/KR100593849B1/en
Application filed by Chemtech Research Inc filed Critical Chemtech Research Inc
Priority to EP05821418A priority Critical patent/EP1863754A1/en
Priority to JP2007542924A priority patent/JP4639236B2/en
Publication of WO2006107134A1 publication Critical patent/WO2006107134A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Definitions

  • the invention relates to a method for preparing valienamine represented by the following formula (1). More particularly, the invention relates to a method for preparing valienamine from acarbose or acarbose derivatives by using a base.
  • Valienamine is a core precursor used for preparing voglibose which is an effective hypoglycemics for treating diabetes, suppressing a sudden rise in blood sugar level after a meal [Carbohydrate Research, 140, 185 (1985); J. Med. Chem., 29, 1038 (1988); U.S. patent No. 4,701,559 (1987)].
  • valienamine The conventional synthetic methods of valienamine are divided into two types.
  • the first type is a total synthesis of valienamine from carbohydrates, and the second type is a preparation of valienamine from validamycin or acarbose having a valienamine moiety therein. Disclosure of Invention Technical Problem
  • valienamine In the total synthesis of valienamine from carbohydrates, valienamine is economically prepared from carbohydrate sources such as D-glucose [Chem. Pharm. Bull., 36,4236 (1988); J. Org. Chem., 57, 3651 (1992)] and D-Xylose [J. Antibiot., 53, 430 (2000)]. However, the total synthesis is inadequate for mass production of valienamine since the synthesis reaction is too complicated due to its at least ten reaction steps.
  • valienamine derivatives were prepared in a yield of about 36% to about 50% by reacting a validoxyamine derivative having benzyl protection group, which is prepared from validamycin, with NBS (N-bromosuccinimide) under a solvent such as DMF (dimethylformamide) or DMSO (dimethylsulfoxide) [Chemistry Letters, 725 (1989); J. Chem. Soc, Perkin Trans I, 3287 (1991)].
  • the method also has some defects because a harmful reagent such as DMF, DMSO, and NBS is used as a solvent or an oxidizing agent, and various by-products are produced.
  • WO 2004/000782 describes a new method for preparing valienamine from acarbose or validamycin under a strong acid solvent of TFA (trifluoroacetic acid).
  • TFA trifluoroacetic acid
  • valienamine can be easily obtained from acarbose or acarbose derivatives using a base, so the present invention is an economic method, which is suitable for the mass production of valienamine.
  • the object of the present invention is to provide a method for preparing valienamine from acarbose or acarbose derivatives using a base to solve the problems resulting from the conventional methods for preparing valienamine.
  • the present invention provides a method for preparing valienamine represented by the formula (1) from acarbose represented by the formula (2) or acarbose derivatives using a base.
  • Acarbose derivatives are compounds having one or more saccharides bonded to a valienamine backbone, and they are generally derivatives having monosaccharide or disaccharide represented by the following formulas.
  • acarbose derivative (disacchaiide) (monosaccharide)
  • a low-priced reagent a base
  • the present invention is an economical method that is suitable for mass production. Best Mode for Carrying Out the Invention
  • inorganic bases and organic bases may be used as a base, for example, it is not particularly limited, hydroxides, carbonates, bicarbonates, phosphates, organic amines, and the like.
  • Suitable bases include hydroxides, e.g. alkali metal hydroxides such as sodium hydroxide (NaOH), potassium hydroxide (KOH), alkaline earth metal hydroxides such as calcium hydroxide (Ca(OH) ), barium hydroxide (Ba(OH) ), tetraammonium hydroxide such as tetramethylammonium hydroxide (NMe OH), tetraethylammonium
  • alkali metal hydroxides such as sodium hydroxide (NaOH), potassium hydroxide (KOH)
  • alkaline earth metal hydroxides such as calcium hydroxide (Ca(OH) ), barium hydroxide (Ba(OH) ), tetraammonium hydroxide such as tetramethylammonium hydroxide (NMe OH), tetraethylammonium
  • NEt OH hydroxide
  • carbonates e.g. metal carbonate (MCO ) (wherein M is alkali metals or alkaline earth metals) such as sodium carbonate (Na CO ), potassium carbonate (K CO ); bicarbonates, e.g. metal bicarbonate (MHCO ) such as sodium bicarbonate (NaHCO ), potassium bicarbonate (KHCO ) ; phosphates such as sodium phosphate tribasic (Na PO ), potassium phosphate tribasic (K PO ), sodium phosphate dibasic (Na HPO ); and organic amines, e.g.
  • MCO metal carbonate
  • MHCO metal bicarbonate
  • phosphates such as sodium phosphate tribasic (Na PO ), potassium phosphate tribasic (K PO ), sodium phosphate dibasic (Na HPO ); and organic amines, e.g.
  • NR R R (wherein R ,R , andR may be the same or different, and are independently alkyl group with a carbon number of 1 to 4) such as diisopropylethylamine, tripropylamine, triethylamine.
  • a base strength may be considered to choose a suitable base among the various bases.
  • the base strength is the most important factor to determine a reaction velocity and a reaction condition. If the base strength is higher, the reaction velocity is relatively faster.
  • the base strength is indicated as a dissociation constant (pKa).
  • pKa dissociation constant
  • the pKa of hydroxyl group (OH ) is 15.7
  • the pKa of carboxyl group (CO ) is 10.3
  • the pKa of organic amine is 10
  • the pKa of triphosphate group (PO ) is 12.7
  • the pKa of bicarbonate group (HCO ) is 6.4.
  • An amount of the base is not particularly limited, but it is preferable to use an excess amount than that of acarbose or its derivatives. Preferably, an amount of the base is preferable to 5 or more equivalents of acarbose or its derivatives.
  • a reaction solvent e.g. water, or a mixture of water and a water-miscible organic solvent may be used for a smooth reaction of the reactants.
  • a preferred water- miscible organic solvent is an alcohol such as methanol, ethanol, and ethylene glycol.
  • An amount of the reaction solvent is not particularly limited, but it is preferable to use 5 times or more by weight of acarbose or its derivatives, and more preferable to use 5 times to 30 times by weight of acarbose or its derivatives. It is preferred that the reflux of the reaction mixture is carried out during the reaction.
  • the preferred reaction temperature is 6O 0 C or higher, and the preferred reaction time is 12 hours or longer. The more preferred reaction temperature is 8O 0 C to 12O 0 C, and the more preferred reaction time is 24 hours to 72 hours.
  • the resulting valienamine from the reaction mixture may be easily purified by a conventional purification method in the art.
  • an ion exchange resin may be used considering the physical properties of valienamine such as water-solubility.
  • the resulting valienamine may be further purified using a purification method such as crystallization.
  • a saccharide(s) combined with a backbone of acarbose are removed using a base, so acarbose derivatives, which are different only from the number of saccharides combined thereto as compared with acarbose, are subject to follow the same reaction path as acarbose. Therefore, the reaction conditions and the purification process of acarbose derivatives are substantially identical with those of acarbose as shown in the following reaction formula 2.
  • the base may be the same defined as above.
  • Acarbose (1Og) and sodium hydroxide (9.3g) were added to water (20OmL) and then refluxed during 48 hours.
  • the reaction mixture was cooled to room temperature, neutralized with IN hydrochloric acid solution, and then concentrated.
  • the concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (l.lg) was obtained.
  • Acarbose (1Og) and potassium hydroxide (10.5g) were added to water (18OmL) and then refluxed during 48 hours.
  • the reaction mixture was cooled to room temperature, neutralized with IN hydrochloric acid solution, and then concentrated.
  • the concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (1.Og) was obtained.
  • Acarbose (1.Og) and calcium hydroxide (1.6g) were added to water (2OmL) and then refluxed during 60 hours.
  • the reaction mixture was cooled to room temperature, and then concentrated.
  • the concentrated reaction mixture was purified with cation exc hange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG- 50). As a result, pure valienamine (0.12g) was obtained.
  • Acarbose (1.Og) and sodium carbonate (2.Og) were added to water (2OmL) and then refluxed during 72 hours.
  • the reaction mixture was cooled to room temperature, and then concentrated.
  • the concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (0.08g) was obtained.
  • Acarbose (1.Og) and sodium bicarbonate (1.8g) were added to water (2OmL) and then refluxed during 72 hours.
  • the reaction mixture was cooled to room temperature, and then concentrated.
  • the concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (0.09g) was obtained.
  • Acarbose derivative (disaccharide, 2.Og) and potassium hydroxide (2.Og) were added to water (4OmL) and then refluxed during 48 hours.
  • the reaction mixture was cooled to room temperature, neutralized with IN hydrochloric acid solution, and then concentrated.
  • the concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (0.2g) was obtained.
  • Acarbose derivative (disaccharide, 2.Og) and sodium hydroxide (1.6g) were added to water (4OmL) and then refluxed during 40 hours. The reaction mixture was cooled to room temperature, and then concentrated. The concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (0.18g) was obtained.
  • Example 9 Preparation of Valienamine from Acarbose (9)
  • Acarbose (2g) and potassium phosphate tribasic (9.8g) were added to water (2OmL) and then refluxed during 45 hours.
  • the reaction mixture was cooled to room temperature, neutralized with IN hydrochloric acid solution, and then concentrated.
  • the concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (0.17g) was obtained.
  • Acarbose (2g) and sodium phosphate tribasic (7.5g) were added to water (2OmL) and then refluxed during 48 hours.
  • the reaction mixture was cooled to room temperature, neutralized with IN hydrochloric acid solution, and then concentrated.
  • the concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (0.19g) was obtained.
  • valienamine (0.16g) was obtained.
  • Industrial Applicability [62] The conventional synthetic methods of valienamine are inadequate for mass production of the product since they are too complicated due to so many reaction steps and they produce many by-products.
  • the present invention provides a method of preparing valienamine suitable for mass production by simplifying the reaction steps and diminishing byproducts. Moreover, the present invention uses a base for the reaction of acarbose or acarbose derivatives so it is a less harmful method in comparison with the conventional methods that uses harmful organic solvents.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention provides a method for preparing valienamine from acarbose or acarbose derivatives by using a base. The present invention provides an improved method for preparing valienamine compared to conventional preparation methods of valienamine by simplifying the reaction steps and diminishing byproducts.

Description

Description METHOD FOR PREPARING VALIENAMINE
Technical Field
[1] The invention relates to a method for preparing valienamine represented by the following formula (1). More particularly, the invention relates to a method for preparing valienamine from acarbose or acarbose derivatives by using a base.
[2]
Figure imgf000002_0001
[3] (1)
Background Art
[4] Valienamine is a core precursor used for preparing voglibose which is an effective hypoglycemics for treating diabetes, suppressing a sudden rise in blood sugar level after a meal [Carbohydrate Research, 140, 185 (1985); J. Med. Chem., 29, 1038 (1988); U.S. patent No. 4,701,559 (1987)].
[5] The conventional synthetic methods of valienamine are divided into two types. The first type is a total synthesis of valienamine from carbohydrates, and the second type is a preparation of valienamine from validamycin or acarbose having a valienamine moiety therein. Disclosure of Invention Technical Problem
[6] In the total synthesis of valienamine from carbohydrates, valienamine is economically prepared from carbohydrate sources such as D-glucose [Chem. Pharm. Bull., 36,4236 (1988); J. Org. Chem., 57, 3651 (1992)] and D-Xylose [J. Antibiot., 53, 430 (2000)]. However, the total synthesis is inadequate for mass production of valienamine since the synthesis reaction is too complicated due to its at least ten reaction steps.
[7] Therefore, a method for preparing valienamine from validamycin or acarbose, which are well known compounds having a valienamine moiety therein, was suggested in order to overcome the above-mentioned drawback of the total synthesis. For example, it is known that valienamine derivatives were prepared in a yield of about 36% to about 50% by reacting a validoxyamine derivative having benzyl protection group, which is prepared from validamycin, with NBS (N-bromosuccinimide) under a solvent such as DMF (dimethylformamide) or DMSO (dimethylsulfoxide) [Chemistry Letters, 725 (1989); J. Chem. Soc, Perkin Trans I, 3287 (1991)]. However, the method also has some defects because a harmful reagent such as DMF, DMSO, and NBS is used as a solvent or an oxidizing agent, and various by-products are produced.
[8] As a solution to the above-mentioned problems, WO 2004/000782 describes a new method for preparing valienamine from acarbose or validamycin under a strong acid solvent of TFA (trifluoroacetic acid). The method is suitable for mass production compared to other conventional methods, but it also has drawbacks in that it uses a relatively expensive and harmful solvent such as TFA. Technical Solution
[9] Accordingly, the present inventors have developed a simple and economic process for preparing valienamine to minimize drawbacks of the prior arts. According to the present invention, valienamine can be easily obtained from acarbose or acarbose derivatives using a base, so the present invention is an economic method, which is suitable for the mass production of valienamine.
Advantageous Effects
[10] The object of the present invention is to provide a method for preparing valienamine from acarbose or acarbose derivatives using a base to solve the problems resulting from the conventional methods for preparing valienamine.
[11] To achieve said object, the present invention provides a method for preparing valienamine represented by the formula (1) from acarbose represented by the formula (2) or acarbose derivatives using a base.
[12]
Figure imgf000003_0001
[13] (1) [14]
Figure imgf000003_0002
[15] (2)
[16] Acarbose derivatives are compounds having one or more saccharides bonded to a valienamine backbone, and they are generally derivatives having monosaccharide or disaccharide represented by the following formulas.
[17]
Figure imgf000004_0001
acarbose derivative (disacchaiide) (monosaccharide)
[18] According to the present invention, a low-priced reagent, a base, is used for preparing valienamine so the present invention is an economical method that is suitable for mass production. Best Mode for Carrying Out the Invention
[19] The method for preparing valienamine according to the present invention is schematized by the following reaction formula.
[20] Reaction formula 1 [21]
Figure imgf000004_0002
vaHeuainine
[22] In the present invention, various inorganic bases and organic bases may be used as a base, for example, it is not particularly limited, hydroxides, carbonates, bicarbonates, phosphates, organic amines, and the like.
[23] Suitable bases include hydroxides, e.g. alkali metal hydroxides such as sodium hydroxide (NaOH), potassium hydroxide (KOH), alkaline earth metal hydroxides such as calcium hydroxide (Ca(OH) ), barium hydroxide (Ba(OH) ), tetraammonium hydroxide such as tetramethylammonium hydroxide (NMe OH), tetraethylammonium
4 hydroxide (NEt OH); carbonates, e.g. metal carbonate (MCO ) (wherein M is alkali metals or alkaline earth metals) such as sodium carbonate (Na CO ), potassium carbonate (K CO ); bicarbonates, e.g. metal bicarbonate (MHCO ) such as sodium bicarbonate (NaHCO ), potassium bicarbonate (KHCO ) ; phosphates such as sodium phosphate tribasic (Na PO ), potassium phosphate tribasic (K PO ), sodium phosphate dibasic (Na HPO ); and organic amines, e.g. NR R R (wherein R ,R , andR may be the same or different, and are independently alkyl group with a carbon number of 1 to 4) such as diisopropylethylamine, tripropylamine, triethylamine.
[24] A base strength may be considered to choose a suitable base among the various bases. In the present invention, the base strength is the most important factor to determine a reaction velocity and a reaction condition. If the base strength is higher, the reaction velocity is relatively faster. Generally, the base strength is indicated as a dissociation constant (pKa). For example, the pKa of hydroxyl group (OH ) is 15.7, the pKa of carboxyl group (CO ) is 10.3, the pKa of organic amine is 10, the pKa of triphosphate group (PO ) is 12.7, and the pKa of bicarbonate group (HCO ) is 6.4. In the present invention, it is preferable to use a base having pKa of at least 6, and it is more preferable to use a base having pKa of at least 10.
[25] An amount of the base is not particularly limited, but it is preferable to use an excess amount than that of acarbose or its derivatives. Preferably, an amount of the base is preferable to 5 or more equivalents of acarbose or its derivatives.
[26] Typically, a reaction solvent, e.g. water, or a mixture of water and a water-miscible organic solvent may be used for a smooth reaction of the reactants. A preferred water- miscible organic solvent is an alcohol such as methanol, ethanol, and ethylene glycol. An amount of the reaction solvent is not particularly limited, but it is preferable to use 5 times or more by weight of acarbose or its derivatives, and more preferable to use 5 times to 30 times by weight of acarbose or its derivatives. It is preferred that the reflux of the reaction mixture is carried out during the reaction. The preferred reaction temperature is 6O0C or higher, and the preferred reaction time is 12 hours or longer. The more preferred reaction temperature is 8O0C to 12O0C, and the more preferred reaction time is 24 hours to 72 hours.
[27] The resulting valienamine from the reaction mixture may be easily purified by a conventional purification method in the art. For example, an ion exchange resin may be used considering the physical properties of valienamine such as water-solubility. Moreover, the resulting valienamine may be further purified using a purification method such as crystallization.
[28] According to the present invention, a saccharide(s) combined with a backbone of acarbose are removed using a base, so acarbose derivatives, which are different only from the number of saccharides combined thereto as compared with acarbose, are subject to follow the same reaction path as acarbose. Therefore, the reaction conditions and the purification process of acarbose derivatives are substantially identical with those of acarbose as shown in the following reaction formula 2.
[29] Reaction formula 2
[30]
Figure imgf000006_0001
acarbose deiivative (disacchaiide) valie ua mine
Figure imgf000006_0002
acai bose deiivative (monosaccharide) valie iia mine
[31] In the reaction formula 2, the base may be the same defined as above.
[32] The present invention is further illustrated by the following examples, but these examples should not be construed as limiting the scope of the invention. Mode for the Invention
[33] Examples
[34] Example 1: Preparation of valienamine from acarbose (Is)
[35] Acarbose (1Og) and sodium hydroxide (9.3g) were added to water (20OmL) and then refluxed during 48 hours. The reaction mixture was cooled to room temperature, neutralized with IN hydrochloric acid solution, and then concentrated. The concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (l.lg) was obtained.
[36] Hydrogen NMR spectrum of the resulting product (valienamine) was as follows:
[37] 1U NMR (D O, 300MHz) 3.35 (m,lH), 3.49(m,2H), 3.80-3.95 (m,2H), 4.02(d,lH),
5.61(d,lH)
[38] Example 2: Preparation of Valienamine from Acarbose (2)
[39] Acarbose (1Og) and potassium hydroxide (10.5g) were added to water (18OmL) and then refluxed during 48 hours. The reaction mixture was cooled to room temperature, neutralized with IN hydrochloric acid solution, and then concentrated. The concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (1.Og) was obtained.
[40] Example 3: Preparation of Valienamine from Acarbose (3)
[41] Acarbose (1.Og) and calcium hydroxide (1.6g) were added to water (2OmL) and then refluxed during 60 hours. The reaction mixture was cooled to room temperature, and then concentrated. The concentrated reaction mixture was purified with cation exc hange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG- 50). As a result, pure valienamine (0.12g) was obtained.
[42] Example 4: Preparation of Valienamine from Acarbose (4)
[43] Acarbose (1.Og) and barium hydroxide octahydrate (6.8g) were added to water
(2OmL) and then refluxed during 55 hours. The reaction mixture was cooled to room temperature, and then concentrated. The concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (0.09g) was obtained.
[44] Example 5: Preparation of Valienamine from Acarbose (5)
[45] Acarbose (1.Og) and sodium carbonate (2.Og) were added to water (2OmL) and then refluxed during 72 hours. The reaction mixture was cooled to room temperature, and then concentrated. The concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (0.08g) was obtained.
[46] Example 6: Preparation of Valienamine from Acarbose (6)
[47] Acarbose (1.Og) and sodium bicarbonate (1.8g) were added to water (2OmL) and then refluxed during 72 hours. The reaction mixture was cooled to room temperature, and then concentrated. The concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (0.09g) was obtained.
[48] Example 7: Preparation of Valienamine from Acarbose Derivative (disaccharide)
Ol
[49] Acarbose derivative (disaccharide, 2.Og) and potassium hydroxide (2.Og) were added to water (4OmL) and then refluxed during 48 hours. The reaction mixture was cooled to room temperature, neutralized with IN hydrochloric acid solution, and then concentrated. The concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (0.2g) was obtained.
[50] Example 8: Preparation of Valienamine from Acarbose Derivative (disaccharide)
(8)
[51] Acarbose derivative (disaccharide, 2.Og) and sodium hydroxide (1.6g) were added to water (4OmL) and then refluxed during 40 hours. The reaction mixture was cooled to room temperature, and then concentrated. The concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (0.18g) was obtained. [52] Example 9: Preparation of Valienamine from Acarbose (9)
[53] Acarbose (5g) and tetramethylammonium hydroxide (2Og) were added to water
(5OmL) and then refluxed during 40 hours. The reaction mixture was cooled to room temperature, neutralized with IN hydrochloric acid solution, and then concentrated. The concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (0.4g) was obtained.
[54] Example 10: Preparation of Valienamine from Acarbose (10)
[55] Acarbose (2g) and potassium phosphate tribasic (9.8g) were added to water (2OmL) and then refluxed during 45 hours. The reaction mixture was cooled to room temperature, neutralized with IN hydrochloric acid solution, and then concentrated. The concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (0.17g) was obtained.
[56] Example 11: Preparation of Valienamine from Acarbose (H)
[57] Acarbose (2g) and sodium phosphate tribasic (7.5g) were added to water (2OmL) and then refluxed during 48 hours. The reaction mixture was cooled to room temperature, neutralized with IN hydrochloric acid solution, and then concentrated. The concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (0.19g) was obtained.
[58] Example 12: Preparation of Valienamine from Acarbose (12)
[59] Acarbose (5g) and sodium phosphate dibasic (16.5g) were added to water (5OmL) and then refluxed during 4 days. The reaction mixture was cooled to room temperature, neutralized with IN hydrochloric acid solution, and then concentrated. The concentrated reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (0.35g) was obtained. [60] Example 13: Preparation of Valienamine from Acarbose Derivative (disaccharide)
(13)
[61] Acarbose (2g) and diisopropyl ethylamine (2OmL) were added to water (5mL) and then refluxed during 3 days. The reaction mixture was concentrated under reduced pressure and then diluted with water (5OmL). The resultant reaction mixture was purified with cation exchange resin (Amberlite IR- 120H) and weak acid cation exchange resin (Amberlite CG-50). As a result, pure valienamine (0.16g) was obtained. Industrial Applicability [62] The conventional synthetic methods of valienamine are inadequate for mass production of the product since they are too complicated due to so many reaction steps and they produce many by-products. The present invention provides a method of preparing valienamine suitable for mass production by simplifying the reaction steps and diminishing byproducts. Moreover, the present invention uses a base for the reaction of acarbose or acarbose derivatives so it is a less harmful method in comparison with the conventional methods that uses harmful organic solvents.

Claims

Claims [1] A method for preparing valienamine represented by the following formula (1) from acarbose or acarbose derivatives by using a base.
(1)
[2] The method according to claim 1, wherein the base is selected from the group consisting of metal hydroxide, metal carbonate, and metal bicarbonate.
[3] The method according to claim 2, wherein the metal hydroxide is sodium hydroxide or potassium hydroxide.
[4] The method according to claim 2, wherein the metal hydroxide is calcium hydroxide or barium hydroxide.
[5] The method according to claim 2, wherein the metal carbonate is sodium carbonate or potassium carbonate.
[6] The method according to claim 2, wherein the metal bicarbonate is sodium bicarbonate or potassium bicarbonate. [7] The method according to claim 1, wherein the base is sodium phosphate tribasic or potassium phosphate tribasic. [8] The method according to claim 1, wherein the base is NR R R (in which R ,R , and R may be the same or different and are independently an alkyl group with a carbon number of 1 to 4) [9] The method according to claim 1, wherein a dissociation constant (pKa) of the base is at least 6. [10] The method according to claim 9, wherein the dissociation constant (pKa) of the base is at least 10.
PCT/KR2005/004093 2005-03-16 2005-12-02 Method for preparing valienamine Ceased WO2006107134A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP05821418A EP1863754A1 (en) 2005-03-16 2005-12-02 Method for preparing valienamine
JP2007542924A JP4639236B2 (en) 2005-03-16 2005-12-02 Method for producing varienamin

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2005-0021852 2005-03-16
KR20050021852 2005-03-16
KR10-2005-0036755 2005-05-02
KR1020050036755A KR100593849B1 (en) 2005-03-16 2005-05-02 How to prepare ballienamine

Publications (1)

Publication Number Publication Date
WO2006107134A1 true WO2006107134A1 (en) 2006-10-12

Family

ID=37073662

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2005/004093 Ceased WO2006107134A1 (en) 2005-03-16 2005-12-02 Method for preparing valienamine

Country Status (2)

Country Link
EP (1) EP1863754A1 (en)
WO (1) WO2006107134A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486602A (en) * 1980-10-06 1984-12-04 Takeda Chemical Industries, Ltd. Valienamine derivatives, their production and use
WO2004000782A1 (en) * 2002-06-25 2003-12-31 B T Gin., Inc. Preparation method of valienamine from acarbose and/or acarbose derivatives using trifluoroacetic acid
WO2004108657A1 (en) * 2003-06-11 2004-12-16 B T Gin., Inc. Preparation method of valienamine using solid catalysts

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486602A (en) * 1980-10-06 1984-12-04 Takeda Chemical Industries, Ltd. Valienamine derivatives, their production and use
WO2004000782A1 (en) * 2002-06-25 2003-12-31 B T Gin., Inc. Preparation method of valienamine from acarbose and/or acarbose derivatives using trifluoroacetic acid
WO2004108657A1 (en) * 2003-06-11 2004-12-16 B T Gin., Inc. Preparation method of valienamine using solid catalysts

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TAIFO MAHMUD ET AL.: "Biosynthetic Studies on the alpha-Glucosidase Inhibitor Acarbose in Actinoplanes sp.: 2-epi-5-epi-Valiolone Is the Direct Precursor of the Valienamine Moiety", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 121, no. 30, 1999, pages 6973 - 6983, XP008047195 *

Also Published As

Publication number Publication date
EP1863754A1 (en) 2007-12-12

Similar Documents

Publication Publication Date Title
US8338645B2 (en) Method for producing a β-alkoxypropionamide
CA2801101C (en) Process for preparing a biphenyl-2-ylcarbamic acid
JPS6241702B2 (en)
EP3424896B1 (en) Method for producing liquid composition containing monoetherate, liquid composition, and method for producing polymerizable compound
BRPI0706719B1 (en) process to produce high purity monopentaerythritol and monopentaerythritol produced by
US20170342100A1 (en) Processes for the preparation of ertugliflozin
US10870671B2 (en) Method of preparation of alpha galactosyl ceramides compounds
US20160115191A1 (en) Novel Polymorph of Regadenoson
JP2825132B2 (en) New method for producing compounds
US10221148B2 (en) Compositions of mono-alkyl ethers of monoanhydro-hexitols, production methods thereof and use of same
JP4639236B2 (en) Method for producing varienamin
WO2006107134A1 (en) Method for preparing valienamine
EP2714691B1 (en) Process for the preparation of 2-amino-9-((2-phenyl-1,3-dioxan-5-yloxy)methyl)-1h-purin-6(9h)-one compound useful in the preparation of valganciclovir
JP5252468B2 (en) Method for synthesizing mycoplasma pneumoniae specific antigen glycolipid
CN110759957B (en) Isoguanosine intermediates, process for producing the same, isoguanosine compounds, process for producing the same, and downstream products thereof
DK170051B1 (en) 14-Chlordaunomycin and acid addition salts thereof, process for the preparation of (2 "R) -4'-O-tetrahydropyranyladriamycin and (2" R) -14-chloro-4'-O-tetrahydropyranyldunomycin
KR100662110B1 (en) Method for preparing tetrazole derivatives
US20140235840A1 (en) New synthesis of fucose
WO2013150020A1 (en) Process for making bendamustine
CN111793071B (en) Synthetic process of augustine
EP1193263B1 (en) Process for producing pyrone compounds
EP2834215B1 (en) Process for making bendamustine
JP2008247889A (en) Process for producing ε-caprolactone compound
US20140235848A1 (en) Method for making a precursor of l-fucose from d-glucose
JPH07138278A (en) Cellobiose derivative and cello-oligomer derivative and methods for producing them

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005821418

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 1342/KOLNP/2007

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 200580036363.X

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 2007542924

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

WWP Wipo information: published in national office

Ref document number: 2005821418

Country of ref document: EP